Using Immersive Virtual Reality to Treat Pediatric Anxiety

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

3 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-09-17

Study Completion Date

2023-02-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Anxiety is a common and impairing problem for children. The principle treatment for pediatric anxiety involves facing a child's fears in a stepwise approach through a therapeutic exercise called exposures. While exposures are effective, some feared situations cannot be confronted in a clinician's office (e.g., heights, public speaking, storms). This poses a logistical challenge in treatment that: (1) takes time away from patient care, (2) leads clinicians to rely on imagined exposures, and/or (3) requires families to complete exposures outside of the therapy visits. This creates a burden for clinicians and families, and impedes treatment success. Immersive virtual reality (VR) presents an innovative solution that allows children to face fears without leaving the clinician's office. While VR has been used to distract children during painful medical procedures, it has not been well examined as a primary treatment for pediatric anxiety. This study proposes to examine the effectiveness and acceptability of using immersive VR exposures to treat children and adolescents with specific phobias.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Using Virtual Reality in Exposure-Based Treatment for Social Anxiety in Youth

NCT03135990

Social Anxiety Social Anxiety Disorder Social Anxiety Disorder of Childhood

TERMINATED NA

Facilitation of Fear Extinction With Yohimbine Hydrochloride in Phobic Participants

NCT00734422

Phobic Disorders

COMPLETED PHASE2/PHASE3

Virtual Reality for AnxIety Disorders - Randomized Controlled Trial

NCT05302518

Social Anxiety Social Phobia

COMPLETED NA

Virtual Reality Exposure Therapy for the Treatment of Social Phobia

NCT02379949

Social Anxiety Disorder

COMPLETED NA

One Session Virtual Reality During Ongoing Treatment for Anxiety: Feasibility in Children and Adolescents

NCT06338800

Anxiety Disorders Exposure Social Anxiety Disorder

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Specific Phobia Specific Phobia, Situational Specific Phobia, Animal Specific Phobia, Natural Environment Childhood Anxiety Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Outcomes assessor is not involved in treatment, and will assess the severity of the participants anxiety.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Virtual Reality Exposure Therapy

Participants will receive a single session of exposure therapy to address specific phobia that includes the use of virtual reality exposures.

Group Type EXPERIMENTAL

Virtual Reality Exposure Therapy

Intervention Type BEHAVIORAL

Participants will receive a single session of virtual reality exposure therapy that targets the participant's specific phobia stimuli.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Virtual Reality Exposure Therapy

Participants will receive a single session of virtual reality exposure therapy that targets the participant's specific phobia stimuli.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 8-17 years (inclusive),
* meet diagnostic criteria for one or more phobias on a structured diagnostic interview (ADIS-C/P). This specifically includes natural environments (e.g., storms, heights) and/or situational settings (e.g., airplanes, public speaking).
* be fluent in English.